Funding pre-announcement: addressing limitations in manufacturing nucleic acid therapeutics. MRC, EPSRC, BBSRC, Innovate UK, UKRI.
The consortium can include academic and industrial organisations in the UK and abroad. The lead organisation must be UK-based.
Consortium proposals should demonstrate how the research outputs could benefit the wider UK research and manufacturing community.
You are encouraged to explore opportunities to collaborate with the Nucleic Acid Therapy Accelerator (NATA) Hub, a new research centre in the UK.
Total fund £6 million.
Further details – https://www.ukri.org/opportunity/addressing-limitations-in-manufacturing-nucleic-acid-therapeutics/
